Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #31869
advertisement
Chen W
23
Showing records 1 to 23 |
Display all abstracts from
Chen W
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Fang F
Molecular Therapy
2022; 30: 1421-1431
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Ye WQ
Chinese Journal of Ophthalmology
2022; 58: 35-40
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Wang QW; Zuo CG
International Journal of Ophthalmology
2022; 15: 65-70
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Deng YX
Chinese Journal of Ophthalmology
2022; 58: 35-40
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Zhuang P
Molecular Therapy
2022; 30: 1421-1431
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Li J
International Journal of Ophthalmology
2022; 15: 65-70
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Feng X
Molecular Therapy
2022; 30: 1421-1431
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Zuo JJ
Chinese Journal of Ophthalmology
2022; 58: 35-40
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Lin XS
International Journal of Ophthalmology
2022; 15: 65-70
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Zhang SD
Chinese Journal of Ophthalmology
2022; 58: 35-40
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu P
Molecular Therapy
2022; 30: 1421-1431
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Chen W
International Journal of Ophthalmology
2022; 15: 65-70
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Wang HO
Chinese Journal of Ophthalmology
2022; 58: 35-40
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu D; Huang H
Molecular Therapy
2022; 30: 1421-1431
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Zhu QL
International Journal of Ophthalmology
2022; 15: 65-70
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Li JY; Zheng QX
Chinese Journal of Ophthalmology
2022; 58: 35-40
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Zhou FQ
International Journal of Ophthalmology
2022; 15: 65-70
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Li L; Chen W
Molecular Therapy
2022; 30: 1421-1431
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Liang YB
Chinese Journal of Ophthalmology
2022; 58: 35-40
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Lin HT
International Journal of Ophthalmology
2022; 15: 65-70
98440
Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Chen W
Chinese Journal of Ophthalmology
2022; 58: 35-40
98578
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Chen WR
International Journal of Ophthalmology
2022; 15: 65-70
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu L; Sun Y; Jiang H; Ye J; Hu Y
Molecular Therapy
2022; 30: 1421-1431
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept